Aurora Cannabis Quick Ratio 2017-2025 | ACB
Historical quick ratio values for Aurora Cannabis (ACB) over the last 10 years.
| Aurora Cannabis Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-09-30 | $0.15B | $0.09B | 1.63 |
| 2025-06-30 | $0.17B | $0.11B | 1.51 |
| 2025-03-31 | $0.17B | $0.08B | 2.16 |
| 2024-12-31 | $0.17B | $0.11B | 1.60 |
| 2024-09-30 | $0.15B | $0.08B | 1.88 |
| 2024-06-30 | $0.17B | $0.09B | 2.03 |
| 2024-03-31 | $0.18B | $0.09B | 1.93 |
| 2023-12-31 | $0.19B | $0.08B | 2.45 |
| 2023-09-30 | $0.19B | $0.09B | 2.11 |
| 2023-06-30 | $0.20B | $0.13B | 1.60 |
| 2022-12-31 | $0.31B | $0.10B | 3.16 |
| 2022-09-30 | $0.41B | $0.13B | 3.20 |
| 2022-03-31 | $0.45B | $0.09B | 4.76 |
| 2021-12-31 | $0.36B | $0.10B | 3.70 |
| 2021-09-30 | $0.40B | $0.10B | 4.13 |
| 2021-03-31 | $0.51B | $0.10B | 4.95 |
| 2020-12-31 | $0.42B | $0.12B | 3.62 |
| 2020-09-30 | $0.19B | $0.17B | 1.07 |
| 2020-03-31 | $0.28B | $0.15B | 1.80 |
| 2019-12-31 | $0.29B | $0.16B | 1.77 |
| 2019-09-30 | $0.29B | $0.35B | 0.83 |
| 2019-03-31 | $0.51B | $0.26B | 1.98 |
| 2018-12-31 | $0.23B | $0.09B | 2.50 |
| 2018-09-30 | $0.43B | $0.08B | 5.68 |
| 2018-06-30 | $0.00B | 0.00 | |
| 2018-03-31 | $0.29B | $0.04B | 6.45 |
| 2017-12-31 | $0.35B | $0.13B | 2.78 |
| 2017-09-30 | $0.14B | $0.02B | 7.45 |
| 2017-06-30 | $0.14B | 0.00 | |
| 2017-03-31 | $0.00B | 0.00 | |
| 2016-12-31 | $0.00B | 0.00 | |
| 2016-09-30 | $0.00B | 0.00 | |
| 2016-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.240B | $0.247B |
| Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $211.725B | 24.40 |
| EssilorLuxottica (ESLOY) | France | $146.103B | 0.00 |
| Stryker (SYK) | United States | $139.118B | 27.62 |
| Boston Scientific (BSX) | United States | $130.559B | 29.85 |
| Medtronic (MDT) | Ireland | $124.048B | 17.19 |
| Medline (MDLN) | United States | $57.961B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.907B | 0.00 |
| Agilent Technologies (A) | United States | $39.588B | 25.02 |
| ResMed (RMD) | United States | $37.591B | 26.02 |
| GE HealthCare Technologies (GEHC) | United States | $37.239B | 17.81 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $20.476B | 23.05 |
| Insulet (PODD) | United States | $20.239B | 62.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.303B | 10.79 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.894B | 0.00 |
| Baxter (BAX) | United States | $10.338B | 8.34 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.457B | 30.41 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.261B | 12.98 |
| Envista Holdings (NVST) | United States | $4.150B | 23.81 |
| BillionToOne (BLLN) | United States | $4.061B | 0.00 |
| ICU Medical (ICUI) | United States | $3.855B | 24.48 |
| Haemonetics (HAE) | United States | $3.378B | 15.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.131B | 14.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.255B | 14.50 |
| Perrigo (PRGO) | Ireland | $2.068B | 5.18 |
| Neogen (NEOG) | United States | $2.012B | 44.05 |
| LeMaitre Vascular (LMAT) | United States | $2.002B | 40.31 |
| AtriCure (ATRC) | United States | $1.942B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.805B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 73.54 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.333B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.176B | 348.86 |
| Capricor Therapeutics (CAPR) | United States | $1.113B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.102B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.002B | 0.00 |
| InMode (INMD) | Israel | $0.881B | 9.96 |
| Valneva SE (VALN) | France | $0.867B | 0.00 |
| Omeros (OMER) | United States | $0.852B | 0.00 |
| CeriBell (CBLL) | United States | $0.814B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.67 |
| Cerus (CERS) | United States | $0.499B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.479B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Canopy Growth (CGC) | Canada | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.423B | 0.00 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| Evolus (EOLS) | United States | $0.337B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 22.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.242B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.27 |
| Accendra Health (ACH) | United States | $0.195B | 1.95 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Exagen (XGN) | United States | $0.106B | 0.00 |
| Biote (BTMD) | United States | $0.106B | 4.64 |
| Sharps Technology (STSS) | United States | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 24.46 |
| Nephros (NEPH) | United States | $0.048B | 34.46 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.67 |
| Jin Medical (ZJYL) | China | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |